Overview of the Opto CLD 2.0 workflow and representative results.
The Beacon Quest™ is an automated 2-chip optofluidic system that allows you to run thousands of miniaturized single-cell assays in parallel and then recover cells of interest.
Find out how the Opto CLD workflow sets a new standard for quality, capacity, and speed in cell line development to let BioPharma get more molecules to the clinic faster.
Learn about improved and expedited cell line development on the Beacon platform from Biogen’s Rachel Ferguson.